Quick Update (What Changed) California Medi-Cal Rx  has announced that GLP-1 medications for weight-loss indications will be excluded from coverage effective January 1, 2026 . Medi-Cal will continue to cover GLP-1s  when used for FDA-approved, non-weight-loss indications  (e.g., type 2 diabetes, ASCVD, CKD ) with appropriate ICD-10 codes and, when required, prior authorization . Practical takeaway (late 2025): If you’re using a GLP-1 for diabetes , Medi-Cal coverage can still apply (PA and...

Introduction: Better Sleep, Better Metabolism Loud snoring, daytime fatigue, stubborn blood pressure, or rising A1C can all point to obstructive sleep apnea (OSA) —a condition tightly linked with weight, heart health, and glucose control . For many adults, a Home Sleep Apnea Test (HSAT)  offers a comfortable, accurate  way to diagnose OSA from home —and it’s often the fastest path to treatment. The American Academy of Sleep Medicine (AASM)  supports HSAT for uncomplicated adults  at increased...

Introduction: New Name, Better Clarity—Same Mission: Your Liver Health Fatty liver disease has a new name — MASLD  (metabolic dysfunction-associated steatotic liver disease)—and MASH  replaces NASH . The update emphasizes the metabolic roots of the condition and removes stigmatizing language, helping patients get clearer, earlier care. At Medical Wellness Doc , Dr. Nisha Kuruvadi  provides comprehensive MASLD evaluation and treatment  for adults in Chula Vista and the South Bay , combining...